Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ApaIRIS in Metastatic Pancreatic Cancer
NCT04101929Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Oct 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib, sponsored by Fudan University. Status: unknown.
02
Drugs
Rivoceranib
Beyond the preview
Go deeper on NCT04101929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101929.